Functionality of Probiotics – Potential for Product Development

益生菌 鼠李糖乳杆菌 双歧杆菌 沙门氏菌 临床试验 健康福利 生物技术 生物 人类健康 致病菌 医学 乳酸菌 细菌 微生物学 环境卫生 生物信息学 传统医学 遗传学
作者
James Dekker,Michael Collett,Jaya Prasad,Pramod K. Gopal
出处
期刊:Bibliotheca nutritio et dieta 卷期号:60: 196-208 被引量:21
标识
DOI:10.1159/000107196
摘要

It is becoming increasingly accepted by consumers that live lactic acid bacteria do exert health benefits when eaten. In addition, it is also becoming recognised that not all probiotic bacteria are equal. It is now no longer just a question of providing sufficient numbers of viable bacteria in a product; industry must also provide proof of efficacy for each strain. In the early 1990s, Fonterra embarked on a programme to develop proprietary probiotic strains, and as a result, commercialised two strains, Bifidobacterium lactis HN019 and Lactobacillus rhamnosus HN001. Over the past decade, Fonterra has developed a significant body of peerreviewed published reports around these strains, including studies showing safety in animal and human trials, protection against pathogens such as Salmonella typhimurium and Escherichia coli O157:H7, modulation of human and animal immune markers at realistic dose rates, and efficacy in human clinical trials. Based on this work, HN019 and HN001 have been applied to several functional foods both by Fonterra (under the DR10 and DR20 brands, respectively) and by third parties (e.g. under the HOWARU brand by Danisco). While the 'gold standard' of proof of efficacy is a phase III clinical trial, ethical considerations as well as expense preclude the use of clinical trials as screening tools for probiotics. Therefore, biomarkers have to be employed to identify strains with probiotic utility, and to define the different positive health benefits of existing probiotic strains. However, as the mechanisms by which most probiotic bacteria exert their health benefits remain unclear, the question of which biomarkers accurately reflect efficacy in vivo remains unresolved. With recent technological advances, and the shift toward probiotics targeted to specific conditions, researchers are beginning to tease out how probiotic bacteria work, and it is this knowledge that will inform biomarker development and improve the ability to offer the market safe and effective probiotic functional foods.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
赘婿应助栖木采纳,获得10
2秒前
当余之从师也完成签到,获得积分10
2秒前
2秒前
Ting发布了新的文献求助10
2秒前
3秒前
李海阳发布了新的文献求助10
3秒前
孤独的哈密瓜数据线完成签到,获得积分10
4秒前
无情落雁发布了新的文献求助10
4秒前
Mali完成签到,获得积分10
4秒前
赘婿应助俏皮诺言采纳,获得10
4秒前
海上明月完成签到,获得积分10
5秒前
chuanan完成签到,获得积分10
5秒前
葛藟萦藤完成签到,获得积分10
6秒前
天下无双发布了新的文献求助10
6秒前
香蕉觅云应助彪壮的绮烟采纳,获得10
6秒前
6秒前
研友_VZG7GZ应助lyb采纳,获得10
7秒前
Nia完成签到 ,获得积分10
7秒前
隐形曼青应助完美迎梦采纳,获得10
7秒前
小马甲应助Rsidereal采纳,获得10
7秒前
7秒前
cp1690完成签到,获得积分10
7秒前
科研通AI2S应助bin采纳,获得10
8秒前
samuel发布了新的文献求助10
8秒前
秋风应助大胆的吐司采纳,获得10
8秒前
kiana完成签到,获得积分10
8秒前
8秒前
隐形曼青应助李海阳采纳,获得10
8秒前
科研废人发布了新的文献求助10
9秒前
9秒前
9秒前
10秒前
yangqisen完成签到 ,获得积分10
10秒前
11秒前
cc完成签到,获得积分10
11秒前
12秒前
10086wm发布了新的文献求助10
12秒前
奔流的河完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
HYDROLYSE ACIDE DE QUELQUES DIOXASPIROCYCLANES 1314
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Navigating Normative Orders. Interdisciplinary Perspectives 800
1 Peter and Christ's Descent to the Dead in Its Early Christian Reception 700
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7746959
求助须知:如何正确求助?哪些是违规求助? 9294978
关于积分的说明 20227342
捐赠科研通 7327342
什么是DOI,文献DOI怎么找? 3308239
关于科研通互助平台的介绍 2460166
邀请新用户注册赠送积分活动 2320108